KDA GROUP DEPLOYS MEDHERIZE ACROSS COMMUNITY PHARMACIES: A MAJOR STEP FORWARD IN THE MANAGEMENT OF ORAL ANTICANCER THERAPIES

Executive Summary

• KDA Group announced the expansion of its Medherize digital platform from hospital use to community pharmacies across Quebec, including Horizon Santé and Jean Coutu locations.
• The rollout aligns with Quebec’s new provincial framework for oral anticancer medication (OAM) management, enabling pharmacists to access oncologists’ treatment plans and patient lab results in real time.
• Executives highlighted the platform’s role in improving adherence, early adverse‑effect detection, and coordinated care among oncologists, pharmacists, and patients.

Key Details

• Deployment Scope: Medherize now active at CHU de Québec, Hôpital du Saint‑Sacrement (≈200 monitored patients) plus community pharmacies under Horizon Santé (22 sites) and a Jean Coutu pharmacy in Quebec City.
• Regulatory Alignment: Fully compliant with the Ministère de la Santé et des Services sociaux’ new OAM framework requiring pharmacist evaluation, counseling, adverse‑effect monitoring, and continuity of care.
• Platform Capabilities:
• Direct access for pharmacists to oncologists’ therapeutic plans.
• Automatic retrieval of laboratory results (including ECGs) via Dossier Santé Québec (DSQ).
• Real‑time patient‑reported adverse‑effect tracking and adherence gap alerts.
• Integrated dispensing, renewal, and secure data sharing across care teams.
• Future Rollout: Additional hospital centers and community pharmacies slated for deployment as early as January 2026.
• Executive Comments:
• Jérôme Lavoie (President, Groupe Horizon Santé) praised Medherize for enabling rigorous monitoring and timely intervention.
• Pierre‑Olivier Sirois (Pharmacist‑Owner, Jean Coutu) called the tool “indispensable” for precision and safety in OAM follow‑up.
• Marc Lemieux (CEO & Chairman, KDA Group) emphasized the platform’s role in completing the care continuum and enhancing patient health outcomes.

Notable Quotes

• “Medherize is a true breakthrough for our pharmacies and our patients… It enables highly rigorous monitoring, allows us to anticipate adverse effects, and helps us intervene at exactly the right moment.” – Jérôme Lavoie, President, Groupe Horizon Santé
• “The Medherize platform is the result of years of work… Seeing physicians, pharmacists, and patients united through a single platform brings our vision to life.” – Marc Lemieux, CEO & Chairman, KDA Group